Showing results (411-420 of 636) with videos related to

Sort By:
Pageof 64
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Oncotarget|May 12, 2016
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cellsEugenio Gaudio, Francesco Paduano, Apollinaire Ngankeu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayEdoardo Missiaglia, Irene Dalai, Stefano Barbi, et al.
Oncotarget|April 15, 2014
Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent mannerJoshua Armenia, Linda Fabris, Francesca Lovat, et al.
Plos One|July 14, 2017
Determination of absolute expression profiles using multiplexed miRNA analysisYunke Song, Duncan Kilburn, Jee Hoon Song, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Plos One|April 20, 2022
Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung CancerMichela Garofalo, Young-Jun Jeon, Gerard J Nuovo, et al.
Oncogene|March 1, 2005
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomasMonica Fedele, Francesca Pentimalli, Gustavo Baldassarre, et al.
Cancer Research|September 19, 2007
MicroRNA signatures in human ovarian cancerMarilena V Iorio, Rosa Visone, Gianpiero Di Leva, et al.
The Journal of Pathology|January 21, 2012
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2Francesca Fornari, Maddalena Milazzo, Pasquale Chieco, et al.
Pageof 64